New Hampshire Business Review - Aug. 30, 2019

Granite Staters need relief from Rx greed

For decades, Big Pharma has raised drug prices with impunity. Here in New Hampshire, the average annual cost of brand-name prescription drug treatment increased 58% between 2012 and 2017, while the annual income for Granite Staters increased only 13%. Prescription…

President is providing hope for kidney patients

President Trump has promised to fight for the forgotten men and women of America — those whose needs and suffering have been too often unheeded by their government. One forgotten group in healthcare is the millions of Americans with some…

Thanks for the great reporting

To the editor, Many thanks to NH Business Review and journalist Bob Sanders for the excellent, in-depth article about the future of fossil-fueled electricity plant operations in New Hampshire. Digging into the details of forward capacity payments and new ISO-NE…

Minimum wage veto creates opportunity

In New Hampshire, we have a lot of reasons to be optimistic about the direction our economy is going. Record low unemployment, record high workforce participation, record high revenue from business taxes, and top economic growth in the region make…

Assessing NH’s new noncompete law

Effective Sept. 8, all noncompete agreements entered on or after that date will be invalid and unenforceable for “low-wage” employees in New Hampshire. The new law primarily defines “low-wage” employees as those earning hourly rates less than or equal to…

Comments

comments